TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms February 8, 1980
TCL Archive In Brief: Peter Jones Is Interim director of USC’s Norris; NIAMS Funds Skin Disease Corse At Yale, Texas January 1, 1993